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Peptidoglycan recognition proteins (PGRPs) are innate immune molecules with a diverse array of functions.
In this issue of Cell Host & Microbe, Maillet and colleagues demonstrate that a Drosophila PGRP, PGRP-LF,
functions as a negative regulator of the Drosophila immune deficiency (IMD) pathway, an innate immune sig-
nalingmechanism responsive toGram-negative bacteria. PGRP-LF deficiency results in unregulated immune
signaling, causing excessive antimicrobial peptide synthesis and, surprisingly, developmental defects.Inflammatory mediators, such as antimi-
crobial peptides, chemokines, and cyto-
kines, are important components of an
effective defense response against in-
fections. However, these mediators are
double-edged swords—they are essen-
tial for defense against pathogens, but ex-
cessive production is harmful to the host.
The signaling pathways that regulate the
synthesis of these mediators often also
regulate other physiological processes,
such as development or apoptosis. It is
important that these pathways are tightly
regulated, and organisms have evolved
several checkpoints that prevent exces-
sive stimulation of immune responses.
PGRPs are innate immunity proteins
that are conserved through evolution
and are present in most invertebrate and
all vertebrate animals. These proteins rec-
ognize peptidoglycan, an essential com-
ponent of the bacterial cell wall. Insects
have many PGRP genes; for example,
Drosophila has 13 PGRP genes that are
spliced into 19 different proteins (Royet
and Dziarski, 2007). Vertebrates have
a smaller number of PGRP genes; there
are four genes in mammals and in lower
vertebrates such as zebrafish (Li et al.,
2007). An increasing understanding of
the functions of PGRPs indicates that all
PGRPs are involved in defense responses
to bacteria. Their precise roles, though,
are different for different PGRPs and
also differ between invertebrate and ver-
tebrate PGRPs. Insect PGRPs have rec-
ognition, signaling, and effector functions,
whereas vertebrate PGRPs are either
amidases or have antibacterial activities.
Drosophila PGRPs are also involved in
the activation of the prophenol oxidase
cascade, which generates antimicrobialproducts, such as melanin and reactive
oxygen species, and some insect PGRPs
are amidases. Despite the growing under-
standing of these proteins, the function(s)
of eight Drosophila PGRPs remains
unknown.
In Drosophila, there are two major
immune signaling pathways, the Toll and
the IMD pathways. PGRPs play a critical
role in both pathways (Royet and Dziarski,
2007). Drosophila PGRP-LC and PGRP-
LE are activated by Gram-negative bacte-
ria and Gram-positive bacilli, and this
initiates the IMD signal transduction path-
way (Figure 1). This pathway results in the
activation of the transcription factor Rel-
ish and expression of diptericin and other
antimicrobial peptides that are primarily
active against Gram-negative bacteria.
The IMD pathway also regulates the
expression of genes involved in apoptosis
and wound healing, which is mediated
through JNK.
In this issue, Maillet, Royet, and col-
leagues describe a new function for a
Drosophila PGRP, PGRP-LF. Their data
demonstrate that PGRP-LF is a negative
regulator of the IMD pathway (Maillet
et al., 2008). Their discovery adds another
mechanism of controlling hyperactivation
of an immune signaling pathway.
Maillet, Royet, and colleagues made
the initial observation that a truncated
form of PGRP-LCa lacking the intracellu-
lar domain is a dominant inhibitor of the
IMD pathway. Similarities in the structure
of PGRP-LC and PGRP-LF prompted
them to ask the following question: is
PGRP-LF a negative regulator of the IMD
pathway? And, if it is, then what is the
mechanismof this regulation? Decreasing
expression of PGRP-LF by RNA inhibitionCell Host & Mresulted in a constitutive, infection-inde-
pendent activation of the IMD pathway,
as measured by the synthesis of the anti-
microbial peptide diptericin. Conversely,
ectopic expression of PGRP-LF blocked
activation of the IMD pathway after infec-
tion. Similar inhibition in the expression
of antimicrobial peptides in cells overex-
pressing PGRP-LF was also recently re-
ported by Steiner’s group (Persson et al.,
2007). Inhibition was only observed when
the flies were injected with E. coli peptido-
glycan but not with S. aureus peptidogly-
can, indicating that the IMD pathway is
negatively regulated by PGRP-LF with the
same specificity for the DAP-type pepti-
doglycan as PGRP-LC.
The authors demonstrated that PGRP-
LF is a membrane protein expressed in
both immune and nonimmune cells. The
surprising presenceof PGRP-LF in nonim-
mune cells suggested that PGRP-LF may
have other functions in addition to regula-
tion of antimicrobial responses. To exam-
ine the role of PGRP-LF in nonimmune
cells, Maillet and colleagues inhibited
expression of PGRP-LF in specific regions
of the wing imaginal disc. The lack of
PGRP-LF in a specific region of the wing
resulted in developmental defects in that
domain. Similar, but more severe defects
were seen in flies overexpressing PGRP-
LC, and the defects were completely
abolished in a PGRP-LC-defective strain,
PGRP-LCE12.Theseresultsconfirmthatan
overactivation of the PGRP-LC/IMD path-
way is responsible for the observed devel-
opmental defects. The role of unregulated
activation of PGRP-LC/IMD pathway and
developmental defects is also observed
in flies lacking the amidases PGRP-SC1
and PGRP-SC2 (Bischoff et al., 2006).icrobe 3, May 2008 ª2008 Elsevier Inc. 273
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bifurcates into two branches: Relish and
JNK (Figure 1). Maillet and colleagues
next examined which of the two branches
is responsible for the developmental
defects. They looked at the expression
of two genes regulated by JNK, puckered
and sulfated, in fat body cells. Reduced
levels of PGRP-LF resulted in increased
expression of both puckered and sul-
fated. Expression of a third gene,mishap-
pen, also a target of JNK, was increased
in the PGRP-LF hypomorph, PGRP-
LF200, compared to wild-type, and this
increase was accompanied by cell death.
Additional data showing the role of PGRP-
LF and JNK in developmental defects
came from genetic studies. Defective
wing formation in PGRP-LF hypomorphs
was rescued by a defective hemipterous
(hep), a kinase upstream of JNK, but not
by defective Dredd or IKK (see Figure 1).
These data confirmed that the JNK
branch, but not the Relish branch, of the
IMD pathway is responsible for these
developmental abnormalities.
The mechanism by which PGRP-LF
inhibits PGRP-LC-mediated activation of
the IMD pathway remains in question.
Maillet and colleagues propose two
possible mechanisms. The first is based
on possible interaction of PGRP-LF with
PGRP-LC. If activation of PGRP-LC re-
quires dimerization of the receptor, in
the absence of peptidoglycan PGRP-LF
would be bound to PGRP-LC, thus
preventing homodimerization and sub-
sequent activation. In the presence of
peptidoglycan, PGRP-LFwould bind pep-
tidoglycan and dissociate fromPGRP-LC.
PGRP-LC would then form a homodimer
and activate the IMD pathway. In the
second mechanism the authors propose
that low levels of peptidoglycan are usu-
ally present in the insect and PGRP-LF
sequesters this peptidoglycan, preventing
binding of peptidoglycan to PGRP-LC and
activation of the IMD pathway. During
an infection, as peptidoglycan levels in-
crease, PGRP-LF would become satu-
rated, and unbound peptidoglycan would
bind PGRP-LC and activate the IMD path-
way. There are some clues supporting
these hypotheses; however, they still
have to be rigorously tested.
The importance of regulating the IMD
pathway is underscored by the fact that
Drosophila has multiple mechanisms that274 Cell Host & Microbe 3, May 2008 ª2008inhibit this signaling pathway (Figure 1).
One way this is achieved is by limiting
the amount of available ligand for stimula-
tion of PGRP-LC. The amidase PGRPs,
PGRP-SC1/2 and PGRP-LB, cleave DAP
peptidoglycan (the ligand for PGRP-LC),
which reduces the activation of the IMD
pathway (Zaidman-Re´my et al., 2006;
Bischoff et al., 2006). In fact, one of the
genes that is activated by the IMD path-
way is PGRP-LB; thus, there is a negative
feedback regulation. The recently identi-
fied protein, Pirk, suppresses signaling
through the IMD pathway and also func-
tions in a negative feedback mechanism
(Kleino et al., 2008). Other regulators
include Caspar, which inhibits DREDD-
dependent cleavage of Relish, preventing
the transcription of downstream genes
Figure 1. Regulation of the Drosophila IMD
Pathway
PGRP-LC, a transmembrane protein, recognizes
DAP-type peptidoglycan fromGram-negative bac-
teria or Gram-positive bacilli and activates the IMD
(immune deficiency) pathway. IMD initiates the
activation of the transcription factor Relish through
the IKK complex, which can be activated through
TAK1 or DREDD. Relish induces transcription of
several antimicrobial peptides including diptericin
and other target genes, such as PGRP-LB and
Pirk. IMD also activates the JNK pathway through
TAK1, and this pathway results in the activation
of the transcription factors AP-1 and STAT and
expression of genes involved in apoptosis and
wound healing. The PGRP-LC/IMD pathway is
negatively regulated at several steps. See text for
details.Elsevier Inc.(Kim et al., 2006). Furthermore, the Relish
and JNK pathways regulate each other
through crosstalk (Park et al., 2004; Kim
et al., 2007).
This study emphasizes the critical and
diverse roles of PGRPs in Drosophila and
opens the possibility of a similar function
for mammalian PGRPs. Mammalian
PGLYRP-2 and three zebrafish PGLYRPs
are N-acetylmuramoyl-L-alanine ami-
dases. Human PGLYRP-1, PGLYRP-3,
PGLYRP-4, and PGLYRP-3:4 and all
zebrafish PGLYRPs are bactericidal for
a wide range of both Gram-positive
and Gram-negative bacteria. Zebrafish
PGLYRP-5 is essential for defense against
bacterial pathogens during the early
stages of development (Li et al., 2007).
Of note, both human PGLYRP-3 and
PGLYRP-4 and Drosophila PGRP-LF all
have two PGRP domains, which may
give themhigher capacity to bind peptido-
glycan. It is therefore likely that the loss of
a similar regulatory protein in mammals
may also upset immune homeostasis
and result in pathology.
REFERENCES
Bischoff, V., Vignal, C., Duvic, B., Boneca, I.G.,
Hoffmann, J.A., andRoyet, J. (2006). PLoS Pathog.
2, e14. 10.1371/journal.ppat.0020014.
Kim,M., Lee, J.H., Lee, S.Y., Kim, E., andChung, J.
(2006). Proc. Natl. Acad. Sci. USA 103, 16358–
16363.
Kim, L.K., Choi, U.Y., Cho, H.S., Lee, J.S., Lee,
W.B., Kim, J., Jeong, K., Shim, J., Kim-Ha, J.,
and Kim, Y.J. (2007). PLoS Biol. 5, e247. 10.
1371/journal.pbio.0050247.
Kleino, A., Myllyma¨ki, H., Kallio, J., Vanha-Aho,
L.M., Oksanen, K., Ulvila, J., Hultmark, D., Valanne,
S., and Ra¨met, M. (2008). J. Immunol. 180, 5413–
5422.
Li, X., Wang, S., Qi, J., Echtenkamp, S.F., Chatter-
jee, R., Wang, M., Boons, G.-B., Dziarski, R., and
Gupta, D. (2007). Immunity 27, 518–527.
Maillet, F., Bischoff, V., Vignal, C., Hoffmann, J.,
and Royet, J. (2008). Cell Host Microbe 3, this
issue, 293–303.
Park, J.M., Brady, H., Ruocco, M.G., Sun, H.,
Williams, D., Lee, S.J., Kato, T., Jr., Richards, N.,
Chan, K., Mercurio, F., et al. (2004). Genes Dev.
18, 584–594.
Persson, C., Oldenvi, S., and Steiner, H. (2007).
Insect Biochem. Mol. Biol. 37, 1309–1316.
Royet, J., and Dziarski, R. (2007). Nat. Rev. Micro-
biol. 5, 264–277.
Zaidman-Re´my, A., Herve´, M., Poidevin, M.,
Pili-Floury, S., Kim, M.S., Blanot, D., Oh, B.H.,
Ueda, R., Mengin-Lecreulx, D., and Lemaitre, B.
(2006). Immunity 24, 463–473.
